These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 19048942)

  • 21. DOT and timely treatment completion among Asian-born immigrant tuberculosis patients.
    Liu SY; Li JH; Schluger NW
    Int J Tuberc Lung Dis; 2005 Aug; 9(8):884-9. PubMed ID: 16104635
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factors influencing the successful treatment of infectious pulmonary tuberculosis.
    Chung WS; Chang YC; Yang MC
    Int J Tuberc Lung Dis; 2007 Jan; 11(1):59-64. PubMed ID: 17217131
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Results of directly observed treatment for tuberculosis in Ensenada, Mexico: not all DOTS programs are created equally.
    Radilla-Chávez P; Laniado-Laborín R
    Int J Tuberc Lung Dis; 2007 Mar; 11(3):289-92. PubMed ID: 17352094
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-hospital DOT and early diagnosis of tuberculosis reduce costs while achieving treatment success.
    Pichenda K; Nakamura K; Morita A; Kizuki M; Seino K; Takano T
    Int J Tuberc Lung Dis; 2012 Jun; 16(6):828-34. PubMed ID: 22507700
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The microbiological and clinical effects of combined therapy according to guidelines on the treatment of pulmonary Mycobacterium avium complex disease in Japan - including a follow-up study.
    Kobashi Y; Matsushima T
    Respiration; 2007; 74(4):394-400. PubMed ID: 16954651
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment outcome among Rwandan and Burundian refugees with sputum smear-positive tuberculosis in Ngara, Tanzania.
    Rutta E; Kipingili R; Lukonge H; Assefa S; Mitsilale E; Rwechungura S
    Int J Tuberc Lung Dis; 2001 Jul; 5(7):628-32. PubMed ID: 11467369
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decentralisation of directly observed treatment in a large African city: evaluation of the experience of Djibouti.
    Bernatas JJ; Ali IM; Ismaël HA; Matan AB; Aboubakar IH
    Int J Tuberc Lung Dis; 2003 Aug; 7(8):724-9. PubMed ID: 12921147
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Study on the efficacy and safety of short-term treatment including fluoroquinolones anti-tuberculosis drugs for rifampicin resistant pulmonary tuberculosis].
    Kang WL; Xie YG; Tan WG; Chu NH; Li L; You YH; Yang YZ; Wang XM; Yan XL; Miao ZP; Duanmu HJ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Feb; 30(2):179-83. PubMed ID: 19565883
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Logistic analysis on risk factors related to smear positive pulmonary tuberculosis].
    Li XT; Ye LX; Shi LY; Xiao AQ; Hou SY; Wang W; Ye JJ; Tang SW; Zhao HH; Xu HT
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Aug; 25(8):658-60. PubMed ID: 15555385
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Directly observed therapy (DOT) is not the entire answer: an operational cohort analysis.
    Mangura B; Napolitano E; Passannante M; Sarrel M; McDonald R; Galanowsky K; Reichman L
    Int J Tuberc Lung Dis; 2002 Aug; 6(8):654-61. PubMed ID: 12150475
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of conversion & cure with initial smear grading among new smear positive pulmonary tuberculosis patients treated with Category I regimen.
    Gopi PG; Chandrasekaran V; Subramani R; Santha T; Thomas A; Selvakumar N; Narayanan PR
    Indian J Med Res; 2006 Jun; 123(6):807-14. PubMed ID: 16885603
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factors that affect sputum conversion and treatment outcome in patients with Mycobacterium avium-intracellulare complex pulmonary disease.
    Ye JJ; Wu TS; Chiang PC; Lee MH
    J Microbiol Immunol Infect; 2007 Aug; 40(4):342-8. PubMed ID: 17712469
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Epidemiological study on factors affecting the hospitalization period of patients with active tuberculosis].
    Fujino T; Fusegawa H; Nishiumi M; Okubo Y; Kakizaki T; Maejima K; Sugimori H
    Kekkaku; 2008 Aug; 83(8):567-72. PubMed ID: 18800648
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Success of community-based directly observed anti-tuberculosis treatment in Mongolia.
    Dobler CC; Korver S; Batbayar O; Oyuntsetseg S; Tsolmon B; Wright C; Solongo B; Marais BJ
    Int J Tuberc Lung Dis; 2015 Jun; 19(6):657-62. PubMed ID: 25946355
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictors of relapse among pulmonary tuberculosis patients treated in a DOTS programme in South India.
    Thomas A; Gopi PG; Santha T; Chandrasekaran V; Subramani R; Selvakumar N; Eusuff SI; Sadacharam K; Narayanan PR
    Int J Tuberc Lung Dis; 2005 May; 9(5):556-61. PubMed ID: 15875929
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Direct observation of tuberculosis treatment by supervised family members in Yasothorn Province, Thailand.
    Akkslip S; Rasmithat S; Maher D; Sawert H
    Int J Tuberc Lung Dis; 1999 Dec; 3(12):1061-5. PubMed ID: 10599008
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outcome of patients treated for tuberculosis in Vaud County, Switzerland.
    Zellweger JP; Coulon P
    Int J Tuberc Lung Dis; 1998 May; 2(5):372-7. PubMed ID: 9613632
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The DOTS strategy for treatment of paediatric pulmonary tuberculosis in South Delhi, India.
    Sharma S; Sarin R; Khalid UK; Singla N; Sharma PP; Behera D
    Int J Tuberc Lung Dis; 2008 Jan; 12(1):74-80. PubMed ID: 18173881
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Usefulness of support during treatment by alignment with health centers and DOT during hospitalization].
    Hoshino K; Machida K; Kawabe Y; Miyamoto M; Hara H; Saitou W; Hirama M; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Nagayama N; Akagawa S; Kurashima A; Yotsumoto H
    Kekkaku; 2005 Apr; 80(4):381-8. PubMed ID: 15991603
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical evaluation of causes of death in patients with pulmonary tuberculosis].
    Takahara M
    Kekkaku; 2004 Dec; 79(12):711-6. PubMed ID: 15782616
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.